[Combined use of carbutamide and butylbiguanide]. 1969

T Bányász, and V Bálint

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002271 Carbutamide A sulfonylurea antidiabetic agent with similar actions and uses to CHLORPROPAMIDE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p277) Aminophenurobutane,Butylcarbamide,Glybutamide,Sulfaninylbutylurea,Bucarban,Bukarban,Diabetal,Glucidoral,Oranil,Oranyl
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001645 Biguanides Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES. Biguanide

Related Publications

T Bányász, and V Bálint
January 1972, Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete,
T Bányász, and V Bálint
July 1969, Das Deutsche Gesundheitswesen,
T Bányász, and V Bálint
January 1982, Methods in enzymology,
T Bányász, and V Bálint
February 1957, The Journal of the Medical Society of New Jersey,
T Bányász, and V Bálint
January 1968, Problemy endokrinologii,
T Bányász, and V Bálint
November 1956, The Nebraska state medical journal,
T Bányász, and V Bálint
November 1956, California medicine,
Copied contents to your clipboard!